Pharma Focus Europe


The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.

Avenacy Launches Eptifibatide Injection in the U.S. Market

Tuesday, April 30, 2024

Avenacy a pharmaceutical company specializing in critical injectable medications has introduced Eptifibatide for Injection in the United States This medication approved by the US Food and Drug Administration serves as a generic equivalent for Integri...

RenAgade Therapeutics expands its dedication to glycobiology through the establishment of GanNA Bio

Monday, April 29, 2024

ReNAgade Therapeutics is broadening its scope in RNA medicine through a collaboration with GanNA Bio This partnership aims to explore the potential of glycobiology in therapeutic applications

Vertex Receives European Commission Approval for KALYDECO® to Treat Cystic Fibrosis in Infants as Young as 1 Month Old

Saturday, April 27, 2024

Vertex Pharmaceuticals has announced today that the European Commission has granted approval for expanding the use of KALYDECO to include infants as young as monthold with cystic fibrosis

Roivant and Kinevant Sciences Complete Enrollment in RESOLVE-Lung, Phase 2 Study Assessing Namilumab for Chronic Pulmonary Sarcoidosis

Friday, April 26, 2024

Roivant and Kinevant Sciences have recently announced the successful completion of enrollment in their Phase study assessing namilumabs efficacy in treating chronic pulmonary sarcoidosis

European Commission Approves FILSPARI® (sparsentan) for IgA Nephropathy Treatment, Joint Announcement by CSL Vifor and Travere Therapeutics

Thursday, April 25, 2024

CSL Vifor and Travere Therapeutics Inc jointly announced today that FILSPARI has been granted conditional marketing authorization by the European Commission

Tetra Pharm Technologies and Glysious Announce Partnership to Develop Transdermal Combination Drugs Targeting the Endocannabinoid System

Thursday, April 25, 2024

Tetra Pharm Technologies and Glysious are excited to announce a new collaboration aiming to revolutionize transdermal drug delivery systems The partnership intends to enhance several of Tetra

Regeneration Biomedical Initiates First Patient in Phase I Clinical Trial Administering Stem Cell Therapy Directly into Alzheimer’s Patients’ Brains

Wednesday, April 24, 2024

Regeneration Biomedical Inc a company focused on developing stem cell therapies for neurodegenerative diseases has reached a significant milestone by dosing the first patient in a Phase

AVEROA Applies to European Medicines Agency for Approval of AVA1014 in Treating Complications Linked to Chronic Kidney Disease

Wednesday, April 24, 2024

Averoa a biopharmaceutical company focused on innovative therapeutic solutions for renal diseases has announced the submission of a marketing authorization application to the European Medicines

Multiply Labs and GenScript Biotech Corporation Join Forces to Automate Cell Isolation and Enrichment in Cell Therapy Manufacturing

Wednesday, April 24, 2024

GenScript Biotech Corporation and Multiply Labs have teamed up to transform the cell therapy manufacturing process Their partnership focuses on automating the intricate cell isolation phase

Ochre Biomedicine and Bailingjia Ingelheim Collaborate on Innovative Treatments for Advanced Liver Disease

Tuesday, April 23, 2024

Ochre Bio a pioneer in the realm of drug development for chronic liver ailments has forged a partnership with Boehringer Ingelheim a prominent German pharmaceutical company Their joint efforts